Lutronic LaseMD Ultra
Non-Ablative Fractional · 1927nm thulium fractional (higher power)
Classification & configurations
Category group: Resurfacing & pigment (ablative, fractional, picosecond, vascular)
Also sold as / variants: LaseMD — applicator and configuration variants of the same platform, covered on this page.
At a glance
- New price
- $60k–$90kSource not documented
- Used asking price
- $40k–$60kSource not documented
- FDA status
- Supplies & recurring costs
- See supply and replacement costs below.
Sources and verified data on file
Data on file
- Recurring consumables
- Not verified
- Used asking prices
- Not verified
- This panel shows a per-treatment supply cost only when a recorded figure has a dated source.
- Bottle prices and estimates may still appear under Treatment & running costs.
- The calculator may include a labeled planning estimate. Review it or enter your own allowance; missing data never means $0.
Figures are reference points, not current offers. Used asking prices are not completed-sale values.
Read FDA-cleared indicationsExact wording from 2 FDA records
K171009 (Lutronic Corporation, 2017)
The LASEMD Laser System is indicated for use in dermatological procedures requiring the coagulation of soft tissue, treatment of actinic keratosis, and treatment of benign pigmented lesions such as, but not limited to lentigos (age spots), solar lentigos (sun spots) and ephelides (freckles).
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K192331 (Lutronic Global, 2019)
The LaseMD LEO Laser System is indicated for use in dermatological procedures requiring the coagulation of soft tissue, treatment of actinic keratosis, and treatment of benign pigmented lesions such as, but not limited to lentigos (age spots), solar lentigos (sunspots) and ephelides (freckles).
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
Page updated: September 4, 2026 · How we verify
Axis runs $0–$90k. Reference figures, not current offers. Used asking prices are not completed-sale values.
Not verified
We hold no per-treatment consumable price for this device from a dated source. Ask the seller for a written per-treatment cost.
Price sourcesSources, dates and configurations
Key factsCompany, specifications and verification dates
| Manufacturer | Lutronic |
|---|---|
| Company | Owner: Hahn & Company (South Korean private equity) (private equity owned, since 2024) · Distribution: direct |
| Parent company | Cynosure Lutronic |
| Brand owner | Lutronic |
| Built by (OEM) | Lutronic Corporation |
| Category | Non-Ablative Fractional |
| Technology | 1927nm thulium fractional (higher power) |
| FDA status | FDA Cleared |
| 510(k) citation | K171009, K192331 |
| New price range | $60k–$90k |
| Used asking range | $40k–$60k |
| Consumables | Not published |
| Launch year | 2021 |
| Pricing | Not published |
| Manufacturer-source documents checked | Not published |
Overview
Faster current-gen thulium
How it worksTechnology and manufacturing
How the technology works
A 1927nm fractional thulium fiber laser — non-ablative, strongly water-absorbed, creating microscopic coagulated columns in the epidermis and superficial dermis while the surface stays intact.
That depth profile excels at sun damage, photodamage, melasma and benign pigment, tone, texture, and pores, with 1-3 days of mild redness and bronzing. Microchannels transiently increase skin permeability — the basis of the serum-infusion protocols.
Patented technology
Kerato-Illumination is Lutronic's name for the brightening effect of controlled superficial remodeling — marketing shorthand for the glow. Real proprietary assets: the high-speed adjustable scanner and the companion cosmeceutical ampoule line (vitamin C, tranexamic acid) designed for the laser-created microchannels.
Origin
Lutronic, South Korea; US sales/support through Cynosure Lutronic.
FDA & regulatory detailClearance timeline, authorization route and citation notes
Family/platform clearance: K171009 names LASEMD and K192331 names LaseMD LEO; no 510(k) naming LaseMD Ultra was located (checked 4 Sep 2026).
FDA-cleared indications (verbatim)
K171009 (Lutronic Corporation, 2017)
The LASEMD Laser System is indicated for use in dermatological procedures requiring the coagulation of soft tissue, treatment of actinic keratosis, and treatment of benign pigmented lesions such as, but not limited to lentigos (age spots), solar lentigos (sun spots) and ephelides (freckles).
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K192331 (Lutronic Global, 2019)
The LaseMD LEO Laser System is indicated for use in dermatological procedures requiring the coagulation of soft tissue, treatment of actinic keratosis, and treatment of benign pigmented lesions such as, but not limited to lentigos (age spots), solar lentigos (sunspots) and ephelides (freckles).
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
Marketed for
Non-Ablative Fractional — 1927nm thulium fractional (higher power)
Marketing claims are the manufacturer's own and are not the same as a cleared indication.
Parent company: Cynosure Lutronic
Legal manufacturer: Lutronic Corporation (South Korea)
Applicant on the FDA record
Lutronic CorporationThe applicant named on the FDA record can differ from the brand shown on the device.
Regulatory data comes from public FDA records and may lag recent updates. Confirm the applicable status and documentation before purchase.
Treatment & running costs
Treatments
Sessions & timing
No treatment schedule documented yet.
What practices charge
No sourced treatment price on file.
Supplies & recurring costs
Supply pricing is not documented with a dated source yet. Request an itemized supply quote.
Annual service & support
No annual service cost documented yet.
Payback calculatorModel your own volume, labor and service costs
Estimate your payback
Pre-filled from our published Lutronic LaseMD Ultra data where we have it. Estimates appear once the required inputs are available. Review and adjust every pre-filled value before relying on the result.
Start from
No verified per-treatment supply cost is on file. Enter your own allowance. Use $0 only if you have confirmed that it applies to your practice.
Pre-filled from the midpoint of the published new-price range
20 is an illustrative default — change it to your volume.
No sourced per-session price on file — enter what you charge.
Required — enter your cost; missing data does not mean $0.
Provider or tech time for one treatment, fully loaded. Enter 0 if you own-operate.
Annual service contract ÷ 12, if you carry one.
Your estimate
Enter price you charge per treatment, consumable cost per treatment to see contribution and a payback range.
This model ignores financing — if you lease or borrow, add your monthly payment. Estimates from your inputs and our published ranges — not a projection, guarantee or financial advice. How we calculate this.
ComplianceScreening and contraindications on the manufacturer's record
Contraindications & screening
Pregnancy, active infection/cold sores in the area, recent isotretinoin, fresh tans, photosensitizing meds; melasma patients must commit to strict photoprotection or results reverse.
Warranty & serviceWhat to confirm in writing before you buy
Before buying new or used, confirm in writing:
- Current warranty coverage
- Included training
- Service terms
Chains using this device
A chain listing does not establish availability at every location.
No confirmed chain deployments recorded yet.
Owner & operator reviews
Write a reviewNo owner or operator reviews yet. Be the first →
Current alternatives
Current catalog models to research. Confirm availability and configuration with the supplier.
History6 tracked changes
Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.
September 4, 2026
science
Unsourced evaluative sentence removed under the opinion-layer gate.
Source: Catalog update — Wave D opinion-layer gate, 2026-09-04
September 4, 2026
treatment pricing
Unsourced evaluative sentence removed under the opinion-layer gate.
Source: Catalog update — Wave D opinion-layer gate, 2026-09-04
September 4, 2026
FDA source URL
Source: Catalog update
August 5, 2026
FDA indication
Source: Catalog update
August 5, 2026
FDA indication
Source: Catalog update
August 1, 2026
Record created
Added to The Aesthetic Index — August 2026
Source: The Aesthetic Index editorial
Cite this data: The Aesthetic Index, "Lutronic LaseMD Ultra — pricing, FDA status and cost to own", aestheticindex.co (accessed September 24, 2026).
Get the full State of Aesthetic Devices 2026 report
A catalog of US-marketed aesthetic and wellness devices — preview it free.
Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.